logo
Select company
Select metric
-1234.35%Return on Equity
VS
Market
1
Sector
3
Industry
3
History
-
$ 3.77Close
$ 0.98 - $ 4.15 52-Week Range
Ticker Information

Ticker

EDIT

Company Name

EDITAS MEDICINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

EDITAS MEDICINE INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EDIT - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 19.19M$ -236.86M-1234.35%
3/31/2025$ 62.42M$ -251.23M-402.48%
12/31/2024$ 134.27M$ -237.09M-176.57%
9/30/2024$ 175.63M$ -210.57M-119.89%
6/30/2024$ 232.01M$ -193.45M-83.38%
3/31/2024$ 294.4M$ -166.13M-56.43%
12/31/2023$ 349.1M$ -153.22M-43.89%
9/30/2023$ 360.46M$ -195.08M-54.12%
6/30/2023$ 399.92M$ -205.79M-51.46%
3/31/2023$ 317.47M$ -218.95M-68.97%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EDITAS MEDICINE INC's latest trailing twelve months (TTM) ROE stands at -20.68%.
  • Over the past 5 years, EDITAS MEDICINE INC's average ROE has been -132.34%.
  • The median ROE for EDITAS MEDICINE INC during this period was -49.98%
  • EDITAS MEDICINE INC reached its highest ROE over the past 5 years at -20.68%.
  • The lowest ROE recorded by EDITAS MEDICINE INC in the same timeframe -1234.35%

EDITAS MEDICINE INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
CCCC : C4 THERAPEUTICS INC -64.1%VYGR : VOYAGER THERAPEUTICS INC -44.25%FENC : FENNEC PHARMACEUTICALS INC -OABI : OMNIAB INC -24.24%SCPH : SCPHARMACEUTICALS INC -SPRO : SPERO THERAPEUTICS INC -163.28%CELU : CELULARITY INC -TKNO : ALPHA TEKNOVA INC -28.27%UTMD : UTAH MEDICAL PRODUCTS INC 10.68%IVVD : INVIVYD INC -257.38%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for EDITAS MEDICINE INC is calculated as follows: Net Inc. Cmn. [ $ -91.25M ] / Equity [ $ 441.15M ]
(=) ROE [ -20.68% ]

EDIT - Return on Equity, Last 5 years

-1234.35%

Minimum

Jun 30, 2025

-20.68%

Maximum

Sep 30, 2020

-132.34%

Average

-49.98%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%